erin, N. Et Al. 2017. Mimetic Peg-M49 Increases Therapeutic Effects Of Pegylated Liposomal Doxorubicin On Poorly Differentiated Breast Carcinoma: Possible Role Of In-Vivo Increased Anti-Tumoral Immune Response.. Citim-2017 Cancer Immunoteraphy And Immunomonitoring , (Prag, Czech Republic), 1-2.

erin, N., TANRIÖVER, G., podnos, A., dilmaç, S., prodeus, A., gariepy, J., ... Gorczynski, R.(2017). Mimetic Peg-M49 Increases Therapeutic Effects Of Pegylated Liposomal Doxorubicin On Poorly Differentiated Breast Carcinoma: Possible Role Of In-Vivo Increased Anti-Tumoral Immune Response. . Citim-2017 Cancer Immunoteraphy And Immunomonitoring (pp.1-2). Prag, Czech Republic

erin, NURAY Et Al. "Mimetic Peg-M49 Increases Therapeutic Effects Of Pegylated Liposomal Doxorubicin On Poorly Differentiated Breast Carcinoma: Possible Role Of In-Vivo Increased Anti-Tumoral Immune Response.," Citim-2017 Cancer Immunoteraphy And Immunomonitoring, Prag, Czech Republic, 2017

erin, NURAY Et Al. "Mimetic Peg-M49 Increases Therapeutic Effects Of Pegylated Liposomal Doxorubicin On Poorly Differentiated Breast Carcinoma: Possible Role Of In-Vivo Increased Anti-Tumoral Immune Response.." Citim-2017 Cancer Immunoteraphy And Immunomonitoring , Prag, Czech Republic, pp.1-2, 2017

erin, N. Et Al. (2017) . "Mimetic Peg-M49 Increases Therapeutic Effects Of Pegylated Liposomal Doxorubicin On Poorly Differentiated Breast Carcinoma: Possible Role Of In-Vivo Increased Anti-Tumoral Immune Response.." Citim-2017 Cancer Immunoteraphy And Immunomonitoring , Prag, Czech Republic, pp.1-2.

@conferencepaper{conferencepaper, author={NURAY ERİN Et Al. }, title={Mimetic Peg-M49 Increases Therapeutic Effects Of Pegylated Liposomal Doxorubicin On Poorly Differentiated Breast Carcinoma: Possible Role Of In-Vivo Increased Anti-Tumoral Immune Response.}, congress name={Citim-2017 Cancer Immunoteraphy And Immunomonitoring}, city={Prag}, country={Czech Republic}, year={2017}, pages={1-2} }